RGT 2.99% 32.5¢ argent biopharma limited

MXC valued at A$0.11 per share based on Edison Investment Research., page-40

  1. 1,078 Posts.
    lightbulb Created with Sketch. 122
    Yes revenue is important for legitimacy and demonstrating a business that is headed in the right direction. But @qinjun88 has a point, at this stage of development and within an emerging sector that is breaking down established norms, the stories, hype, excitement, FOMO call it what you will, drives investor and insto buy in. Now when you combine the fundamentals with the stories / hype / excitement, the SP will rocket. When that wave goes back out, the rocket goes in reverse as we saw post VC failure
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
32.5¢
Change
-0.010(2.99%)
Mkt cap ! $15.73M
Open High Low Value Volume
32.0¢ 32.5¢ 32.0¢ $2.203K 6.783K

Buyers (Bids)

No. Vol. Price($)
1 1666 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 8746 1
View Market Depth
Last trade - 14.31pm 17/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.